Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095

Ítems similars

• A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers
  per: Szepeshazi, Karoly, et al.
  Publicat: (1997)
• Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
  per: Pinski, J., et al.
  Publicat: (1994)
• Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin
  per: Kanashiro, Celia A., et al.
  Publicat: (2003)
• Synergistic effects of bombesin and epidermal growth factor on cancers.
  per: Liebow, C, et al.
  Publicat: (1994)
• Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt
  per: Hohla, Florian, et al.
  Publicat: (2007)